한국어 버전：펩타이드 원료 수입 준비(한국 시장)
South Korea · Destination-specific import and receiving qualification
Preparing peptide raw-material imports for South Korea destination review
Korea assigns cosmetic raw materials to the Cosmetics Act: a Korean responsible seller registered with MFDS owns the filings, functional-cosmetic claims face pre-market review, ingredient lists are screened against MFDS prohibited and restricted lists, and each cosmetic import passes a KPTA pre-import notification before customs clearance. Non-cosmetic industrial uses instead fall under K-REACH, which explicitly exempts cosmetics and their raw materials. This preparation framework identifies the record set and open questions for the Korean destination; it does not determine legality, classification or admissibility for any particular material or shipment.
Who should own each import-preparation workstream?
| Workstream | Responsible parties | Inputs to reconcile | Required evidence and limit |
|---|---|---|---|
| Destination and substance/use scope | Buyer with supplier technical input | The exact destination (South Korea), material identity, specification, intended B2B application and destination-use context; Korean law assigns cosmetic raw materials to the Cosmetics Act route, while non-cosmetic industrial uses fall under K-REACH — the applicable framework follows the declared use. | A documented substance/use review against Korea's current official sources; no use-based classification is assumed here. |
| Responsible-seller (importer) registration interface | Korean importer/distributor and its regulatory reviewer | Whether the importing entity holds current registration as a Responsible Cosmetic Distribution Business with MFDS; foreign manufacturers do not file directly — the Korean responsible seller owns the formula data, safety evidence and filings for regulatory purposes. | Confirmed local role allocation and current registration status before shipment; this template does not appoint a responsible seller. |
| Functional-cosmetic boundary review | Korean responsible seller and its MFDS-facing reviewer | Whether the intended finished formulation would make functional-cosmetic claims (whitening, anti-wrinkle, UV protection, hair colouring, hair-loss relief and similar categories); functional cosmetics need pre-market MFDS review, or the lighter report route where the active ingredient, content and claim match the notified Standards and Test Methods for Functional Cosmetics. | A current category and claims review with dated sources; general-cosmetic status is not assumed for any peptide ingredient. |
| Ingredient-list screen | Importer's technical/compliance reviewer | Screening of the substance against MFDS prohibited and restricted ingredient lists (a large negative list plus concentration limits for preservatives, UV filters and hair-dye ingredients); a restricted ingredient used outside its conditions requires MFDS approval. | A current, dated screen of the full ingredient list; raw-material supply documents are not a substitute for the finished-formula screen. |
| Batch, receiving and per-shipment documents | Supplier quality contact, Korean responsible seller and buyer receiving/quality team | Specification revision, COA and analytical records, packing details, receiving acceptance criteria; for cosmetic imports the responsible seller files a KPTA pre-import notification for each shipment, and supporting evidence (e.g., BSE/TSE-related statements where applicable) is prepared before the first export. | Current batch-linked records plus the responsible seller's confirmed per-shipment filing workflow; discrepancies are resolved before acceptance. |
| Labeling, language and OEM-boundary review | Formulator/brand, Korean responsible seller and a competent Korean reviewer | Korean-language mandatory labeling for finished cosmetics (all ingredients, responsible-seller identification, dates, cautions), affixed before distribution; and a clear written boundary that a raw-material supply relationship does not transfer finished-product registration, claims or market-release responsibilities to the supplier. | A current, official-source-based Korean labeling review and a signed raw-material/OEM responsibility split; literal translation is not a compliance basis. |
| Route, clearance and exception handling | Buyer, supplier, Korean responsible seller and appointed logistics parties | Agreed trade term, actual route and gateway, alignment of customs declaration data with the KPTA import notification and the Standard Customs Clearance Notice, handling constraints and exception contacts. | Approved order-specific terms and route evidence; no transit time, clearance or delivery outcome is guaranteed. |
How should the buyer and importer sequence the review?
- 1
Fix the destination, the use and the responsibility boundary first
Name South Korea as the destination, document the intended use, and write down who is the Korean responsible seller before anything else; cosmetic raw materials sit under the Cosmetics Act, not K-REACH, and the supplier's role stops at raw-material documentation.
- 2
Name the responsible parties
Record the Korean responsible seller, the MFDS-facing reviewer, supplier quality contacts, the forwarder and the receiving reviewers before discussing document handoff.
- 3
Complete Korea official-source review
Have qualified parties screen the substance against MFDS prohibited/restricted lists, confirm whether any functional-cosmetic category or report route applies, and — for non-cosmetic industrial uses — screen against KECI and any K-REACH registration or notification duty; retain sources, dates and open questions.
- 4
Reconcile documents and order terms
Match product, batch, invoice, packing and per-shipment filing data to the agreed scope, confirm Korean label and document expectations including KPTA pre-import notification timing, then resolve discrepancies before dispatch or receiving.
Which document handoffs need separate review?
Product and destination review
Material identity, specification, composition and intended-use brief, plus dated official-source and qualified-party conclusions applicable to South Korea.
Batch and receiving review
Use the quality and documentation guide to frame COA and analytical questions, then agree the actual batch and receiving package.
Trade and exception review
Reconcile the shipping-term template and sample/returns framework with approved order-specific responsibilities.
What must remain unresolved until evidence is approved?
No destination classification, registration, clearance or delivery commitment is made on this page. Current official sources for South Korea, substance/use conclusions, responsible-seller registration status, functional-cosmetic category review, labeling review, per-shipment notification workflow, actual route terms and named technical/compliance reviewers are still required before indexing.
- Do not describe any material on this site as "Korea compliant" or "MFDS approved"; filings and approvals belong to the Korean responsible seller, not to the supplier's documents.
- Do not imply that a raw-material supply relationship includes finished-cosmetic private-label manufacturing, registration or market-release responsibility; that boundary is fixed in writing per order.
- Do not treat literal translation of ingredient lists or labels as Korean compliance; MFDS screens and Korean labeling review must use current official sources.
- Do not reuse Japanese-market assumptions (PMD Act, MAH, quasi-drug logic) for Korea; the responsible-seller model, functional-cosmetic categories and KPTA notification are Korean-specific.
- Do not state HS codes, duty rates, KPTA timelines or clearance outcomes for any shipment; these are determined in the responsible seller's filings and customs declaration.
- Do not treat raw-material documents (COA, invoice, packing list) as proof of notification, approval, admissibility or receiving acceptance.
- Do not copy this matrix to another destination without a separate official-source review.